These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 10745441)

  • 1. Local drug delivery via transvascular injection.
    Gonschior P; Backfisch G; Muth G; Schiele R; Vogel-Wiens C; Pahl C; Sponer G
    J Invasive Cardiol; 1999 Oct; 11(10):600-7. PubMed ID: 10745441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new catheter for prolonged local drug application.
    Gonschior P; Goetz AE; Huehns TY; Höfling B
    Coron Artery Dis; 1995 Apr; 6(4):329-34. PubMed ID: 7655717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perivascular delivery of losartan with surgical fibrin glue prevents neointimal hyperplasia after arterial injury.
    Moon MC; Molnar K; Yau L; Zahradka P
    J Vasc Surg; 2004 Jul; 40(1):130-7. PubMed ID: 15218473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local arterial drug delivery: a golden gun without bullets?
    Schwartz RS; Lubbe D; Altman J; Holmes DR
    J Invasive Cardiol; 1999 Oct; 11(10):620-1. PubMed ID: 10745445
    [No Abstract]   [Full Text] [Related]  

  • 5. Development and evaluation of carvedilol-loaded transdermal drug delivery system: In-vitro and in-vivo characterization study.
    Kshirsagar SJ; Bhalekar MR; Mohapatra SK
    Drug Dev Ind Pharm; 2012 Dec; 38(12):1530-7. PubMed ID: 22356303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevation of cyclosporin A blood levels during carvedilol treatment in renal transplant patients.
    Kaijser M; Johnsson C; Zezina L; Backman U; Dimény E; Fellström B
    Clin Transplant; 1997 Dec; 11(6):577-81. PubMed ID: 9408688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local delivery of NO-donor molsidomine post-PTA improves haemodynamics, wall mechanics and histomorphometry in atherosclerotic porcine SFA.
    Rolland PH; Bartoli JM; Piquet P; Mekkaoui C; Nott SH; Moulin G; Amabile P; Mesana T
    Eur J Vasc Endovasc Surg; 2002 Mar; 23(3):226-33. PubMed ID: 11914009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of carvedilol after intravenous and oral administration in conscious healthy dogs.
    Arsenault WG; Boothe DM; Gordon SG; Miller MW; Chalkley JR; Petrikovics I
    Am J Vet Res; 2005 Dec; 66(12):2172-6. PubMed ID: 16379664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereoselective disposition and tissue distribution of carvedilol enantiomers in rats.
    Fujimaki M
    Chirality; 1992; 4(3):148-54. PubMed ID: 1586585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of local intravascular drug-delivery catheter systems.
    Gonschior P; Pahl C; Huehns TY; Gerheuser F; Erdemci A; Larisch K; Dellian M; Deil S; Goetz AE; Lehr HA
    Am Heart J; 1995 Dec; 130(6):1174-81. PubMed ID: 7484766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of local molsidomine delivery from a hydrogel-coated angioplasty balloon catheter in the atherosclerotic porcine model.
    Rolland PH; Mekkaoui C; Palassi M; Friggi A; Moulin G; Piquet P; Bartoli JM
    Cardiovasc Intervent Radiol; 2003; 26(1):65-72. PubMed ID: 12491015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local delivery of platelets with encapsulated iloprost to balloon injured pig carotid arteries: effect on platelet deposition and neointima formation.
    Banning A; Brewer L; Wendt M; Groves PH; Cheadle H; Penny WJ; Crawford N
    Thromb Haemost; 1997 Jan; 77(1):190-6. PubMed ID: 9031472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new approach for local intravascular drug delivery. Iontophoretic balloon.
    Fernández-Ortiz A; Meyer BJ; Mailhac A; Falk E; Badimon L; Fallon JT; Fuster V; Chesebro JH; Badimon JJ
    Circulation; 1994 Apr; 89(4):1518-22. PubMed ID: 8149516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local drug delivery: impact of pressure, substance characteristics, and stenting on drug transfer into the arterial wall.
    Baumbach A; Herdeg C; Kluge M; Oberhoff M; Lerch M; Haase KK; Wolter C; Schröder S; Karsch KR
    Catheter Cardiovasc Interv; 1999 May; 47(1):102-6. PubMed ID: 10385171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and efficacy of carvedilol in chronic hemodialysis patients with hypertension.
    Miki S; Masumura H; Kaifu Y; Yuasa S
    J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S62-8. PubMed ID: 1721982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomised, cross-over, comparative bioavailability trial of matrix type transdermal drug delivery system (TDDS) of carvedilol and hydrochlorothiazide combination in healthy human volunteers: a pilot study.
    Agrawal SS; Aggarwal A
    Contemp Clin Trials; 2010 Jul; 31(4):272-8. PubMed ID: 20382272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the percutaneous intramyocardial injection for local myocardial treatment.
    Rezaee M; Yeung AC; Altman P; Lubbe D; Takeshi S; Schwartz RS; Stertzer S; Altman JD
    Catheter Cardiovasc Interv; 2001 Jun; 53(2):271-6. PubMed ID: 11387620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the pharmacokinetic properties of bisoprolol and carvedilol in healthy dogs.
    Beddies G; Fox PR; Papich MD; Kanikanti VR; Krebber R; Keene BW
    Am J Vet Res; 2008 Dec; 69(12):1659-63. PubMed ID: 19046015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction profile of carvedilol: investigations with digitoxin and phenprocoumon.
    Caspary S; Merz PG; Brei R; Harder S
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):537-8. PubMed ID: 1490823
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.